Institute for general pharmacology & toxicology

The Institute of General Pharmacology offers a wide variety of expertises in the areas of cancer, wound healing, acute and chronic inflammation, signal transduction and kidney and skin diseases. With the help of our well characterized in vitro and in vivo models we are able to perform differential gene expression analysis (genomics, proteomics), to investigate signal transduction pathways and to develop and test therapy modalities. The design of gene delivery vectors and other forms of tumor-specific treatment is of special interest.

Director:

Prof. Dr. J. Pfeilschifter

Group leaders:

Dr. K.-F. Beck (Nitric oxide-dependent gene expression, in vitro model systems)
PD Dr. W. Eberhardt (Extracellular matrix, inflammation)
PD Dr. S. Frank (Inflammation, wound healing, diabetes; in vivo test systems)
PD Dr. A. Huwiler (Signal transduction)
PD Dr. M. Kaszkin (Phospholipase A2, active substance analysis)
PD Dr. H. Mühl (Active substance analysis, signal transduction, inflammation)
Dr. E.-M. Westphal (gene therapy; prodrug converting enzymes and NSAIDs as anti-cancer drugs; in vivo model systems)